VAIM Co., Ltd.

VAIM Co., Ltd. specializes in injectable dermal fillers and skin contouring devices. Their portfolio includes products like Juvelook Glam, Juvelook Volume, and Juvelook, which are designed for soft tissue augmentation and volume restoration. Additionally, they produce Lenisna for skin tightening and Vivabella for aesthetic enhancement, primarily used in cosmetic and reconstructive treatments.

VAIM Co., Ltd. is headquartered in South Korea. The company’s location influences its regulatory compliance framework, particularly for devices marketed in regions like the European Union.

VAIM Co., Ltd.’s devices are registered in the EU’s eudamed database, which is the official portal for medical device information under European Union regulations. This ensures transparency and compliance with EU requirements for high-risk medical devices.

VAIM Co., Ltd.’s devices fall under Class III classification, which is the highest risk category for medical devices. This classification applies to products like injectable fillers and skin contouring devices due to their potential risks, such as infection, adverse reactions, or permanent damage, requiring rigorous pre-market authorization and post-market surveillance.